Open AccessOndansetron, ramosetron, or palonosetron: Which is a better choice of antiemetic to prevent postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy?
Author(s) -
Sarbari Swaika,
Anirban Pal,
Surojit Chatterjee,
Dipanwita Saha,
Nidhi Dawar
Publication year - 2011
Publication title -
al-banǧ. maqālāt wa abḥāṯ fī al-taẖdīr wa-al-in’āš
Language(s) - English
Resource type - Journals
ISSN - 0259-1162
DOI - 10.4103/0259-1162.94761
Subject(s) - palonosetron , ondansetron , antiemetic , medicine , postoperative nausea and vomiting , vomiting , laparoscopic cholecystectomy , nausea , anesthesia , cholecystectomy , surgery
Postoperative nausea and vomiting (PONV) is a serious concern in patients undergoing laparoscopic cholecystectomy (LC), with an incidence of 46 to 72%. The purpose of this study was to compare the antiemetic efficacy of intravenous (iv) ondansetron 8 mg, ramosetron 0.3 mg, and palonosetron 0.075 mg for prophylaxis of PONV in high-risk patients undergoing LC.